Innovex International, Inc. 8K

Innovex International, Inc. entered into an underwriting agreement for a secondary offering of 5,000,000 shares of common stock by existing stockholders to Barclays Capital Inc. at $28.71 per share, with closing expected on August 10, 2026.

On August 6, 2026, Innovex International, Inc. entered into an underwriting agreement with Barclays Capital Inc., pursuant to which certain existing stockholders (the “Selling Stockholders”) agreed to sell 5,000,000 shares of the Company’s common stock at a purchase price of $28.71 per share in a registered secondary offering under the Company’s effective Form S-3 shelf registration statement (File No. 333-282178), with closing and payment for the shares scheduled to occur on August 10, 2026 through The Depository Trust Company. The agreement sets forth the terms of the offering, confirms that Barclays is acting solely as an arm’s length counterparty rather than a fiduciary, specifies that the shares will be sold by the Selling Stockholders and not issued by the Company, and includes standard representations, warranties and covenants by the Company and the Selling Stockholders regarding the accuracy of the registration statement and prospectus, absence of material adverse changes, valid authorization of the agreement, compliance with securities and other laws, and other customary conditions to closing.

Filing Facts

CIK

1042893

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-342567

Alert Tier

6